Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and ...

The expanded age indication is supported by results from a 3-year FDA clinical trial that included 629 eyes. The EVO ICL demonstrated “a strong safety profile” with no reported cases of pupillary ...

The cardiology landscape is rapidly evolving. Novel risk factors and new tools are reshaping CV risk assessment and management.Healio | Cardiology Today asked cardiologists: What are the most ...

Women who were prescribed menopausal hormone therapy had modestly reduced risk for all-cause mortality vs. those who did not receive a prescription, according to data published in The BMJ.

An interim analysis of safety data showed no increased risk associated with Pfizer’s respiratory syncytial virus vaccine when ...

Certain social determinants and psychological factors may elevate a person’s risk for new persistent opioid use after surgery, according to a systematic review and meta-analysis.Enrollment in Medicaid ...

The median predicted survival age of a patient with cystic fibrosis in 2020 to 2024 was 65 years, a 19-year increase from 2015 to 2019, according to data from the 2024 Cystic Fibrosis National ...

Pregnant women receiving vegetable-focused food delivery from 32 weeks’ gestation to birth ate a larger daily serving of nonstarchy vegetables vs. women not receiving this intervention, according to a ...

In this expert perspective from Hawaiian Eye 2026, Jennifer M. Loh, MD, discusses Ocubio’s role in providing an “easy way” for patients with neurotrophic keratitis or dry eye to receive serum tears ...

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights the latest issue’s cover story describing medical groups’ lobbying efforts amidst an ...

In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press ...

Orthopedic surgery has always evolved alongside technology, from advances in biomaterials to minimally invasive techniques.Today, however, the pace of innovation is accelerating. AI, robotic ...